TwinTrader.com announces the publication of Breakout for AMLN; highlighting public companies on the move and what’s behind the surge.
Investors can view all of the Breakouts and other articles for free by visiting:
http://www.TwinTrader.com
“Amylin Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development and commercialization of medicines for diabetes, obesity and other diseases in the United States. It sells BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection for the treatment of patients with type II diabetes…
“Barron’s reported that pharmaceuticals are becoming targets of takeovers. SeekingAlpha published a story about this expected trend. Amylin Pharmaceuticals is mentioned as an attractive takeover in this theme…
“RSI still reads neutral and MACD has been bullish since mid-July. Buyers of this stock may want to look at the $33 level before committing. Consolidation after a big run-up is expected...”
To read the entire article visit http://www.TwinTrader.com
Join the fastest growing investor community at:
http://www.stocknetworkonline.com/
TwinTrader LLC (TT) is not a registered broker-dealer and is not a registered investment advisor. No investor should base their investments decisions upon any act or omission of TT. TT makes no representations or warranties, and none may be relied upon. The purchase and sale of any securities must be made solely with the assistance of a registered broker-dealer and/or investment advisor. TT may, and you should assume that TT does, own shares in the companies profiled on this site. TT intends to sell its shares at times and as otherwise allowed by the securities laws which may negatively affect the performance of the stock price. TT affiliates, officers, directors and employees may have also bought or may buy shares in the companies profiled on this site and may sell, and profit from the sale of, such shares at any time. Except as required by the securities laws, TT will not advise when it or its affiliates, officers, directors and employees intend to sell and will not offer any opinion as to when others should sell. Any recent increase in volume or increase in stock price may be due to trading by TT or its affiliates, officers, directors and employees. TT will not be responsible for any gains or losses due to investing based on any opinions contained on this site. Receipt of the stock profiles, either via e-mail or directly from this site, is not in any way a solicitation or recommendation to buy or sell and should be used for information purposes only. Short-term trading can be extremely risky. As with any investment decision, careful research should be done before making any decision to invest.
Source: TwinTrader.com
TwinTrader.com
Scott Sanchez, (214)-317-5947
scott@twintrader.com
